
|Articles|December 10, 2007
Latebreakers: Final DEA rule OKs multiple Schedule II Rxs
A final rule from the DEA allows doctors to give patients multiple prescriptions for up to a 90-day supply of Schedule II controlled substances.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA-Approved Sunscreen Filter Bemotrizinol Debuts in New US Products
2
FDA Approves XFG-Targeted COVID-19 Vaccines From Multiple Companies
3
FDA Approves Stelara for Pediatric Ulcerative Colitis
4
COVID-19 in 2026: Why the Virus Still Threatens Vulnerable Patients
5




























